The present invention relates to a dosage form which comprises amorphous calcium L-5-methylfolate and cysteine as stabilizing agent and optionally, further auxiliary agents.The dosage forms according to the invention resolves the problem of unstability of amorphous calcium L-5-methylfolate to the oxidation by air.